AbbVie has signed on to Iambic's new AI drug discovery model, according to a report by FirstWord Pharma.
Summaries like this, in your inbox every morning.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, LINE, or Slack.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
Google opened preorders for the first Googlebook models, priced from US$899
Amazon blocked Meta's AI agent Muse from shopping on Amazon.com, GeekWire reported September 20
Nvidia guided for $108.0 billion in fiscal third-quarter revenue, with a footnote that it assumes no Data Cent…
SpaceX introduced Grok 4.7, which averaged $4.69 per task on CursorBench 4.0, ahead of GPT-5.6 Sol and Fable 5…
Tesla's robot team ran intensive supplier audits across China's Yangtze River Delta last week, covering Ningbo…
Gartner predicted in June 2026 that 70% of mainframe modernization projects begun in 2026 will fail, and point…
